Rethinking ovarian cancer genomics: where genome-wide association studies stand?

被引:6
作者
Pinto, Ricardo [1 ,2 ]
Assis, Joana [1 ,3 ]
Nogueira, Augusto [1 ,3 ]
Pereira, Carina [1 ,4 ]
Pereira, Deolinda [5 ]
Medeiros, Rui [1 ,6 ,7 ]
机构
[1] Portuguese Inst Oncol, Res Ctr, Mol Oncol & Viral Pathol Grp, Edificio Labs 4 Piso, P-42004072 Oporto, Portugal
[2] Abel Salazar Inst Biomed Sci, ICBAS, Rua Jorge Viterbo Ferreira 228, P-4050313 Oporto, Portugal
[3] Univ Porto, Fac Med, FMUP, Alameda Prof Hernani Monteiro, P-4200319 Oporto, Portugal
[4] Univ Porto, Fac Med, Ctr Hlth Technol & Serv Res, CINTESIS, Rua Dr Placido da Costa, P-4200450 Oporto, Portugal
[5] Portuguese Inst Oncol, Oncol Dept, Rua Dr Antonio Bernardino Almeida, P-4200072 Oporto, Portugal
[6] Portuguese League AgainstCanc NRNorte, Res Dept, Estrada Interior Circunvalaco 6657, P-4200172 Oporto, Portugal
[7] FernandoPessoa Univ, Fac Hlth Sci, CEBIMED, Praca 9 Abril 349, P-4249004 Oporto, Portugal
关键词
GWAS; ovarian cancer; polymorphisms; validation; PLATINUM-BASED CHEMOTHERAPY; COMMON GENETIC-VARIATION; NEGATIVE BREAST-CANCER; SUSCEPTIBILITY LOCI; LUNG-CANCER; POOLED DNA; MISSING HERITABILITY; COLORECTAL-CANCER; ACTIVITY PROFILE; COMPLEX TRAITS;
D O I
10.2217/pgs-2017-0108
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Genome-wide association studies (GWAS) allow the finding of genetic variants associated with several traits. Regarding ovarian cancer (OC), 15 GWAS have been conducted since 2009, with the discovery of 49 SNPs associated with disease susceptibility and 46 with impact in the clinical outcome of patients (p < 5.00 x 10(-2)). Among them, 14 variants reached the genome-wide significance (p < 5.00 x 10(-8)). Despite the results obtained, they should be validated in independent sets. So far, five validation studies have been conducted which could confirm the association of 12 OC susceptibility SNPs. Consequently, post-GWAS studies are crucial unravel the biological plausibility of GWAS' findings and the allelic spectrum of OC.
引用
收藏
页码:1611 / 1625
页数:15
相关论文
共 121 条
  • [1] Ovarian cancer evolution through stochastic genome alterations: defining the genomic role in ovarian cancer
    Abdallah, Batoul Y.
    Horne, Steven D.
    Kurkinen, Markku
    Stevens, Joshua B.
    Liu, Guo
    Ye, Christine J.
    Barbat, Justin
    Bremer, Steven W.
    Heng, Henry H. Q.
    [J]. SYSTEMS BIOLOGY IN REPRODUCTIVE MEDICINE, 2014, 60 (01) : 2 - 13
  • [2] Assis J, 2013, INT J CLIN EXP MED, V6, P552
  • [3] A Genome-Wide Association Study of Prognosis in Breast Cancer
    Azzato, Elizabeth M.
    Pharoah, Paul D. P.
    Harrington, Patricia
    Easton, Douglas F.
    Greenberg, David
    Caporaso, Neil E.
    Chanock, Stephen J.
    Hoover, Robert N.
    Thomas, Gilles
    Hunter, David J.
    Kraft, Peter
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (04) : 1140 - 1143
  • [4] Punctuated Evolution of Prostate Cancer Genomes
    Baca, Sylvan C.
    Prandi, Davide
    Lawrence, Michael S.
    Mosquera, Juan Miguel
    Romanel, Alessandro
    Drier, Yotam
    Park, Kyung
    Kitabayashi, Naoki
    MacDonald, Theresa Y.
    Ghandi, Mahmoud
    Van Allen, Eliezer
    Kryukov, Gregory V.
    Sboner, Andrea
    Theurillat, Jean-Philippe
    Soong, T. David
    Nickerson, Elizabeth
    Auclair, Daniel
    Tewari, Ashutosh
    Beltran, Himisha
    Onofrio, Robert C.
    Boysen, Gunther
    Guiducci, Candace
    Barbieri, Christopher E.
    Cibulskis, Kristian
    Sivachenko, Andrey
    Carter, Scott L.
    Saksena, Gordon
    Voet, Douglas
    Ramos, Alex H.
    Winckler, Wendy
    Cipicchio, Michelle
    Ardlie, Kristin
    Kantoff, Philip W.
    Berger, Michael F.
    Gabriel, Stacey B.
    Golub, Todd R.
    Meyerson, Matthew
    Lander, Eric S.
    Elemento, Olivier
    Getz, Gad
    Demichelis, Francesca
    Rubin, Mark A.
    Garraway, Levi A.
    [J]. CELL, 2013, 153 (03) : 666 - 677
  • [5] Integrated genomic analyses of ovarian carcinoma
    Bell, D.
    Berchuck, A.
    Birrer, M.
    Chien, J.
    Cramer, D. W.
    Dao, F.
    Dhir, R.
    DiSaia, P.
    Gabra, H.
    Glenn, P.
    Godwin, A. K.
    Gross, J.
    Hartmann, L.
    Huang, M.
    Huntsman, D. G.
    Iacocca, M.
    Imielinski, M.
    Kalloger, S.
    Karlan, B. Y.
    Levine, D. A.
    Mills, G. B.
    Morrison, C.
    Mutch, D.
    Olvera, N.
    Orsulic, S.
    Park, K.
    Petrelli, N.
    Rabeno, B.
    Rader, J. S.
    Sikic, B. I.
    Smith-McCune, K.
    Sood, A. K.
    Bowtell, D.
    Penny, R.
    Testa, J. R.
    Chang, K.
    Dinh, H. H.
    Drummond, J. A.
    Fowler, G.
    Gunaratne, P.
    Hawes, A. C.
    Kovar, C. L.
    Lewis, L. R.
    Morgan, M. B.
    Newsham, I. F.
    Santibanez, J.
    Reid, J. G.
    Trevino, L. R.
    Wu, Y. -Q.
    Wang, M.
    [J]. NATURE, 2011, 474 (7353) : 609 - 615
  • [6] Role of common genetic variants in ovarian cancer susceptibility and outcome: progress to date from the ovarian cancer association consortium (OCAC)
    Bolton, K. L.
    Ganda, C.
    Berchuck, A.
    Pharaoh, P. D. P.
    Gayther, S. A.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2012, 271 (04) : 366 - 378
  • [7] Common variants at 19p13 are associated with susceptibility to ovarian cancer
    Bolton, Kelly L.
    Tyrer, Jonathan
    Song, Honglin
    Ramus, Susan J.
    Notaridou, Maria
    Jones, Chris
    Sher, Tanya
    Gentry-Maharaj, Aleksandra
    Wozniak, Eva
    Tsai, Ya-Yu
    Weidhaas, Joanne
    Paik, Daniel
    Van den Berg, David J.
    Stram, Daniel O.
    Pearce, Celeste Leigh
    Wu, Anna H.
    Brewster, Wendy
    Anton-Culver, Hoda
    Ziogas, Argyrios
    Narod, Steven A.
    Levine, Douglas A.
    Kaye, Stanley B.
    Brown, Robert
    Paul, Jim
    Flanagan, James
    Sieh, Weiva
    McGuire, Valerie
    Whittemore, Alice S.
    Campbell, Ian
    Gore, Martin E.
    Lissowska, Jolanta
    Yang, Hanna P.
    Medrek, Krzysztof
    Gronwald, Jacek
    Lubinski, Jan
    Jakubowska, Anna
    Le, Nhu D.
    Cook, Linda S.
    Kelemen, Linda E.
    Brook-Wilson, Angela
    Massuger, Leon F. A. G.
    Kiemeney, Lambertus A.
    Aben, Katja K. H.
    van Altena, Anne M.
    Houlston, Richard
    Tomlinson, Ian
    Palmieri, Rachel T.
    Moorman, Patricia G.
    Schildkraut, Joellen
    Iversen, Edwin S.
    [J]. NATURE GENETICS, 2010, 42 (10) : 880 - +
  • [8] Why the missing heritability might not be in the DNA
    Bourrat, Pierrick
    Lu, Qiaoying
    Jablonka, Eva
    [J]. BIOESSAYS, 2017, 39 (07)
  • [9] An Expanded View of Complex Traits: From Polygenic to Omnigenic
    Boyle, Evan A.
    Li, Yang I.
    Pritchard, Jonathan K.
    [J]. CELL, 2017, 169 (07) : 1177 - 1186
  • [10] Genetic susceptibility to sporadic ovarian cancer: A systematic review
    Braem, M. G. M.
    Schouten, L. J.
    Peeters, P. H. M.
    van den Brandt, P. A.
    Onland-Moret, N. C.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2011, 1816 (02): : 132 - 146